Yoga for Depression

Summary

Clinical research on yoga as an adjunctive treatment for depression has grown substantially over the past decade. Multiple randomized controlled trials suggest that regular yoga practice may reduce depressive symptoms in mild to moderate cases, though head-to-head comparisons with conventional therapies remain limited. Preliminary evidence suggests yoga may modulate neurochemical pathways involved in mood regulation.

Key findings

Meta-analyses of controlled trials suggest yoga interventions produce reductions in Hamilton Depression Rating Scale scores, with effect sizes varying by study quality. Small biomarker studies report increases in thalamic/serum GABA levels and reductions in inflammatory markers following regular practice, with limited replication. Practices combining slow movement with breath awareness appear promising, but the optimal session frequency and “dose” are not established.

Methodology

Studies primarily employ randomized controlled designs with active control conditions such as walking or health education. Standardized yoga protocols including Hatha and Iyengar styles are most common. Outcome measures include self-report scales (BDI, PHQ-9) and biological markers. Follow-up periods typically range from 8-12 weeks.

Criticism / Limitations

Blinding is inherently difficult in yoga interventions, introducing potential expectancy effects. Many studies struggle with participant attrition, particularly in longer trials. The optimal “dose” of yoga remains unclear, and cultural factors may influence treatment response across diverse populations.

Verification notes

Results are consistent with broader literature on exercise and depression. Several RCTs, mostly small to moderate in size, support short-term symptom improvements, though implementation in diverse clinical settings requires further validation.

• Audited against Wikipedia (September 2026).